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Abstract
Purpose: Primary care databases are increasingly used for researching pregnancy,
eg, the effects of maternal drug exposures. However, ascertaining pregnancies, their
timing, and outcomes in these data is challenging. While individual studies have
adopted different methods, no systematic approach to characterise all pregnancies
in a primary care database has yet been published. Therefore, we developed a new
algorithm to establish a Pregnancy Register in the UK Clinical Practice Research
Datalink (CPRD) GOLD primary care database.
Methods: We compiled over 4000 read and entity codes to identify pregnancy‐
related records among women aged 11 to 49 years in CPRD GOLD. Codes were
categorised by the stage or outcome of pregnancy to facilitate delineation of preg-
nancy episodes. We constructed hierarchical rule systems to handle information from
multiple sources. We assessed the validity of the Register to identify pregnancy out-
comes by comparing our results to linked hospitalisation records and Office for
National Statistics population rates.
Results: Our algorithm identified 5.8 million pregnancies among 2.4 million women
(January 1987‐February 2018). We observed close agreement with hospitalisation
data regarding completeness of pregnancy outcomes (91% sensitivity for deliveries
and 77% for pregnancy losses) and their timing (median 0 days difference, interquar-
tile range 0‐2 days). Miscarriage and prematurity rates were consistent with popula-
tion figures, although termination and, to a lesser extent, live birth rates were
underestimated in the Register.
Conclusions: The Pregnancy Register offers huge research potential because of its
large size, high completeness, and availability. Further validation work is underway to
enhance this data resource and identify optimal approaches for its use.
KEYWORDS
electronic health records, pharmacoepidemiology, pregnancy, pregnancy outcome, pregnancy
trimesters, United Kingdom
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1 | INTRODUCTION
Pregnant women are a key study population for many important
health questions, including understanding the safety and effectiveness
of drugs and vaccines given during pregnancy, effects of other in utero
exposures on foetal outcomes, and long‐term sequelae of pregnancy
complications. Electronic health primary care record (EHR) datasets
contain a wealth of maternal and infant data, and their large size
enables them to be used to assess rare exposures and outcomes in
real‐world settings.1 However, ascertaining the timing and outcomes
of pregnancies in such data presents challenges, since the start, end,
and trimester dates of pregnancies are not systematically recorded.2
For studies investigating potential teratogenic risk factors, it is essen-
tial to estimate pregnancy start dates accurately, as this enables
exposures during the first trimester, the critical period of organogene-
sis, to be identified.
Primary care datasets are increasingly used for pregnancy
research, with researchers developing a multitude of methods to
characterise pregnancies therein.3-11 These methods typically involve
some of the following components: simple imputation3,5 (subtracting
a fixed duration from the pregnancy outcome date to derive the
start date); mapping markers of pregnancy (diagnoses, appointments,
or procedures indicative of a pregnancy) to pregnancy out-
comes7,8,12; and utilising additional information in patient records
to infer the start of pregnancy3,5,6,9,13 (eg, last menstrual period
(LMP) dates, antenatal dating scans, or gestational age at birth).
While some researchers attempt to characterise a variety of preg-
nancy outcomes,7,8,13 others restrict to live births.3,12 Hence, the
methods vary in their complexity, accuracy, and the situations in
which they can be useful. Validation studies show that utilising mul-
tiple sources of information improves date estimation.2,14 However,
even the more complex approaches are limited by the exclusion of
pregnancies with no recorded outcome,7,9 outcomes with no earlier
pregnancy marker,9,13 or conflicting pregnancy records within the
same woman.7,9,13 To date, there has been no published, systematic
approach to characterise each documented pregnancy, including
those with no recorded outcome, and to use all available pregnancy
data in a primary care database.
The UK Clinical Practice Research Datalink GOLD primary care
database (henceforth referred to as CPRD) is one of the largest,
best‐established primary care databases for research. Our study
aimed to develop, apply, and validate a new algorithm to identify
pregnancies in CPRD, to facilitate and improve the quality of preg-
nancy research using CPRD. Building on our initial work to identify
deliveries in CPRD,15 the CPRD Mother‐Baby link (restricted to live
births) and other EHR‐based pregnancy algorithms,2,16,17 we sought
to identify all documented pregnancies regardless of the complete-
ness of recording or the type of outcome, to establish a Pregnancy
Register in CPRD. Here, we describe our algorithm and the
Pregnancy Register it generates, present our validation findings,
and highlight key strengths and limitations of this data resource to
enable researchers to understand its scope and optimise its use for
pregnancy research.
2 | METHODS
2.1 | Data sources
CPRD is a database of routinely collected, anonymised primary care
health records for over 15 million patients, representing the UK popu-
lation in age, sex, and ethnicity.18 CPRD comprises records of consul-
tations, diagnoses and symptoms, prescriptions, tests, referrals to and
feedback from secondary care, health‐related behaviours, and all addi-
tional care administered as part of routine general practice. In the
United Kingdom, general practitioners (GPs) are the main point of con-
tact for nonemergency health issues, including pregnancy. Thus, CPRD
is a rich source of pregnancy data relating to antenatal and postnatal
care and pregnancy outcomes. A practice‐specific family number
enables mother‐infant pairs to be algorithmically linked (the CPRD
Mother‐Baby link). Patients from 56% of CPRD GOLD practices can
be linked to additional datasets, including Hospital Episode Statistics
(HES), which comprises records of all patient care delivered by NHS
hospitals in England, including maternity data. We used CPRD GOLD
primary care data to generate the Pregnancy Register and linked
HES data to validate it. The International Scientific Advisory Commit-
tee (ISAC)‐approved protocol for this study (ref 11_058) is provided in
the Supporting information.
2.2 | Generating pregnancy code lists
CPRD GOLD codes clinical events using the hierarchical read classifi-
cation system. GPs may also record additional, structured data using
entity codes. To maximise ascertainment of pregnancy data, we gener-
ated lists of read and entity codes relating to pregnancy. We identified
an extensive set of pregnancy‐related terms from relevant chapters of
the read hierarchy, used in combination with wildcards, to identify
potentially relevant read codes. We then compared these with existing
code lists7 to identify additional codes. We identified relevant entity
KEY POINTS
• Large primary care databases are valuable sources of
pregnancy data for studies of pregnancy.
• Identifying pregnancies, their timing, and outcomes in
these databases presents challenges for researchers.
• We developed an algorithm to determine pregnancy
episodes in the UK Clinical Practice Research Datalink
(CPRD) GOLD primary care database.
• Our algorithm generated a Pregnancy Register
comprising 5.8 million pregnancies among 2.4 million
women from CPRD GOLD general practices spanning
three decades.
• This data resource provides a useful tool to enhance
CPRD‐based pregnancy research.
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codes from the “child health surveillance” and “maternity” chapters.
We excluded irrelevant codes and categorised our final selection of
codes in 21 nonmutually exclusive categories shown with examples in
Table 1. Our complete categorised code lists of 4200 read codes
and 37 entity codes and details of how the algorithm uses the
codes and accompanying data fields in each category are provided in
Data S2 to S4.
2.3 | Study population
We identified all female patients aged 11 to 49 years from CPRD
GOLD practices during the period between January 1, 1987, and
February 28, 2018, with individual‐level research quality data and with
a pregnancy code in their primary care records. We extracted all their
pregnancy records and additional data on timing and gestational age at
birth from live‐born infants identified in the Mother‐Baby link. We
applied no further restrictions. Hence, records relating to time periods
before patients joined a practice or before practices' data were
deemed to be of a research quality standard (indicated by the practice
up‐to‐standard date) were included. This enabled us to generate a
complete pregnancy profile for each patient.
2.4 | Summary of the pregnancy algorithm
The pregnancy algorithm used all available pregnancy data (from read
and entity codes) to determine the timing of pregnancy (start, end,
and trimester dates), the outcome (live birth, stillbirth, or early preg-
nancy loss), and additional details including whether a pregnancy was
preterm, postterm, or multiple. The algorithm began by classifying each
patient's pregnancy outcome records into distinct pregnancy episodes
(combining multiple records relating to the same outcome) and estimat-
ing pregnancy end dates. Delivery records were considered separately
from early pregnancy loss records. In keeping with UK clinical prac-
tice,19 we considered the onset of the LMP to be the pregnancy start.
We derived pregnancy start dates from multiple read and entity
codes in the following order of priority: (a) estimated date of delivery
(EDD), (b) estimated date of conception (EDC), (c) LMP, (d) antenatal
records indicating gestational age, and (e) gestational age at birth (from
maternal and infant records). EDD was preferred over EDC and LMP
as these codes were considered more likely to derive from an antena-
tal ultrasound scan, and hence to be more reliable, than a record of
LMP. Indeed, codes relating to a scan were used preferentially when
available. Codes indicating gestational age during pregnancy or at
delivery often specified a range rather than a precise number of
weeks, hence these were positioned further down the hierarchy. Addi-
tionally, because codes indicating gestational age at delivery were
considered more prone to delayed recording, which could result in a
delayed estimated start date, these were used only in the absence of
codes in other categories. In the absence of such records, we applied
a fixed duration, consistent with the type of pregnancy, to impute
the start date. We estimated the timing of trimesters to be LMP
onset to 13 completed weeks for the first trimester, weeks 14 to 26
for the second, and week 27 to delivery for the third. The entity codes
and associated data fields used to derive pregnancy start and end
dates are shown inTable 2. Characteristics of each pregnancy episode,
including the type of delivery or pregnancy loss (when recorded), were
determined from the pregnancy codes, which the algorithm assigned
to the episode. Figure 1 illustrates the eight stages of our algorithm.
Full details are provided in the Supporting information.
The Pregnancy Register lists and describes all pregnancies identi-
fied in CPRD GOLD by our algorithm. Each record represents a unique
TABLE 1 Pregnancy code categories and example codes
Pregnancy Code
Category
Number of
Read
Codesa
Example
Read
Code Description
Antenatal 1446 62…00 Patient pregnant
Late pregnancy
(≤3 wk before
delivery)
35 L281.00 Premature rupture of
membranes
Third trimester 47 62N8.00 A/N 32 week examination
Delivery 1030 L20..11 Spontaneous vaginal
delivery
Stillbirth 29 Q4z..15 Stillbirth NEC
Ectopic 28 L03..00 Ectopic pregnancy
TOP 148 L052.11 Medical abortion—
complete
Miscarriage 70 L04..00 Spontaneous abortion
Probable TOP 5 L05..12 Termination of pregnancy
Molar pregnancy 11 L002.00 Complete hydatidiform
mole
Unspecified
pregnancy loss
96 L0z..00 Pregnancy with abortive
outcome NOS
Blighted ovum 2 L010.00 Blighted ovum
Postnatal (≤8 wk
after delivery)
902 62S7.00 Postnatal examination
normal
Other postnatalb 97 E204.11 Postnatal depression
Preterm 28 L142.11 Premature delivery
Postterm 18 L150.00 Postterm pregnancy
Multiple 96 L210.00 Twin pregnancy
LMP 1 1513.00 Last menstrual period—first
day
EDD 6 1514.12 Estimated date of delivery
EDC 3 Z22C500 Estimated date of
conception
Pregnancy related
(timing
uncertain)b
371 L12..00 Hypertension complicating
pregnancy/childbirth/
puerperium
Abbreviations: A/N = antenatal; EDC = estimated date of conception;
EDD = estimated date of delivery; LMP, last menstrual period; NEC = not
elsewhere classified; NOS = not otherwise specified; TOP, termination of
pregnancy.
aCategories are not mutually exclusive; hence, codes may appear in more
than one category.
bCodes in these categories are not used to determine pregnancy start and
end dates due to uncertainty around which stage of pregnancy or the post-
natal period they refer to.
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pregnancy episode. There may be more than one episode per woman.
For pregnancies resulting in live births, patient identifiers of babies
identified in the Mother‐Baby link are provided. Full descriptions of
the Pregnancy Register variables are shown in Table S1.
2.5 | Validation methods
2.5.1 | Internal validation
We assessed the validity of our algorithm to identify pregnancy out-
comes occurring in hospital by comparison with linked HES Admitted
Patient Care data (HES APC, henceforth referred to as HES).
Data sources and study population
We included women aged 11 to 49 years, who were registered with
an HES‐linked CPRD GOLD practice from England and eligible for
linkage. Women were required to have a pregnancy outcome recorded
in the Pregnancy Register (January 2016 prototype) or in HES (Set 13)
between April 1, 1997, and December 31, 2015. Both data sources
were concurrent during this period.
HES diagnoses are based on the International Classification of Dis-
ease clinical coding system (ICD‐10), and procedures are coded using
the OPCS Classification of Interventions and Procedures (OPCS‐4).
Deliveries were determined from the HES maternity file, and addi-
tional data on pregnancy outcomes were extracted using OPCS codes
for end‐of‐pregnancy or postnatal procedures and ICD codes for early
TABLE 2 Entity codes used to derive pregnancy start and end dates
Entity Code Description Estimation of Pregnancy Date
To estimate the start of pregnancy
60 Ante‐natal booking Event date minus the number of weeks specified in the
relevant data fielda (allowing a maximum of 42 wk).61 Ante‐natal consultation
154 Alpha fetoprotein
119 Gestation—maternity outcome Estimated date of delivery (derived by the algorithm) minus
the number of weeks specified in data 1 (allowing a maximum of 42 wk).120 Gestational age of baby
129 Pregnancy dates Expected delivery date (in data 2) minus 280 d.
284 Maternity ultra sound scan Expected delivery date (in data 8) minus 280 d. If data 8 is missing, use
event date minus the number of weeks specified in data 2 (allowing a
maximum of 42 wk).
To estimate the end of pregnancy
35 Hearing (6 wk) Event date minus 42 d.
80 Muscle tone for 6 wk (CHS)
84 Vision CHS 6 wk
63b CHS examination If CHS stage (in data 2) = birth, use event date. If CHS stage = 6 wk,
use event date minus 42 d.
69 Postnatal examination Event date minus the number of days or weeks specified in data 2
(allowing a maximum of 56 d or 8 wk).150 Postnatal visit
78 Stages of labour Event date
93 Delivery details
112 CHS Apgar score at 1 min
115 Delivery details (CHS)
119 Gestation—maternity outcome
120 Gestational age of baby
126 Maternity infant details
128 Perineum
144 Maternity outcome placenta
145 CHS Apgar score at 5 min
100 Perinatal problems Event date minus 7 d.
114c Pregnancy outcome Discharge date (in data 1) minus 2 d.
Abbreviation: CHS, Child Health Surveillance.
aData 1 (entity codes 60 and 61), data 8 (entity code 154).
bUsed only if CHS stage specifies birth or 6 weeks.
cUsed to estimate either a delivery date or an early pregnancy loss date (depending on the outcome specified in the record). All other entity codes are used
to estimate delivery dates only.
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pregnancy loss and combined into pregnancy episodes. Full details of
the approach and codes used to determine pregnancy episodes in
HES are provided in the Supporting information.
Analysis
We compared the occurrence of deliveries and early pregnancy losses
in HES to those captured in the Register and assessed agreement.
Follow‐up for pregnancy outcomes in both data sources began at
the latest of: the patient's 11th birthday, the date they joined the prac-
tice, the practice up‐to‐standard date, or the start of HES coverage
(April 1, 1997). Follow‐up ended at the earliest of: their 49th birthday,
the date they left the practice or died, the practice's last collection
date, or the end of CPRD coverage (December 31, 2015). We consid-
ered a match to occur if a woman's pregnancy outcome dates in CPRD
FIGURE 1 Stages of the Clinical Practice Research Datalink (CPRD) GOLD pregnancy algorithm [Colour figure can be viewed at
wileyonlinelibrary.com]
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and HES were less than 12 weeks apart. We chose 12 weeks to allow
for potential errors in date estimation in the Register, assuming that
pregnancy outcomes recorded in the two data sources within
12 weeks apart represent the same event. We calculated the potential
positive predictive value (PPV) (recognising that not all women deliver
in hospital), completeness of recording, and accuracy of timing of
pregnancy outcomes in the Register, using HES as the reference stan-
dard. Additionally, for matched deliveries (those in both data sources
and less than 12 weeks apart), we assessed concordance on gesta-
tional age (completed weeks).
We explored reasons for incomplete matching in sensitivity
analyses. First, to allow for possible delays in GPs recording pregnancy
outcomes occurring in hospital, we excluded Register‐recorded preg-
nancies in the first 6 months of follow‐up (when calculating PPV), and
HES‐recorded pregnancies in the last 6 months of follow‐up (when cal-
culating sensitivity). As shown in Figure 2, including these pregnancies
potentially underestimates agreement between the two data sources.
Second, to allow for possible retrospective recording of past pregnan-
cies soon after a patient joins a practice20 (Figure 3), we excluded
pregnancies recorded in the Register during the first year of registration,
as historical pregnancies are unlikely to be captured in HES.
2.5.2 | External validation
We assessed the validity of the Pregnancy Register estimates of live
birth, miscarriage, termination, and prematurity rates by comparing
with national vital statistics and published estimates.
Data sources and study population
To ensure comparability with external estimates regarding age, geo-
graphic region, and time, we restricted our study population to women
aged 15 to 44 years, registered with CPRD GOLD practices in England
and Wales from 2010 to 2015. Patient follow‐up began at the latest
of: their 15th birthday, the date they joined the practice (plus 1 year,
to avoid ascertainment of historical pregnancies), the practice up‐to‐
standard date, or January 1 of the calendar year. Follow‐up ended at
the earliest of their 44th birthday, the date they left the practice or
died, the practice's last data collection date, or December 31 of the
calendar year. This external validation used a later version of the Preg-
nancy Register (February 2018).
Analysis
We estimated live birth and termination rates in 2015, defined as
the number of live birth deliveries, and the number of terminations,
each per 1000 women‐years. We chose person‐time as a denomina-
tor (rather than the mid‐year number of women) to allow for the
dynamic nature of our cohort. In secondary analyses, we expanded
our definition of termination to include “probable termination” and
“unspecified loss” (see example codes in Table 1). We conducted
sensitivity analyses, extending follow‐up to include patients' first
year of registration, to increase ascertainment of live births and ter-
minations among women who joined a practice while pregnant. We
estimated the miscarriage rate over a 5‐year period (2010‐2015),
defined as the number of miscarriages divided by the total number
of pregnancies with known outcomes. In a secondary analysis, we
expanded our definition of miscarriage to include “unspecified loss.”
We estimated the prematurity rate in 2015, defined as the number
of preterm deliveries (less than 37 weeks of gestation) per thousand
births (live births and stillbirths). The primary analysis included as
preterm those deliveries with a preterm flag in the Register (based
on evidence in read and entity codes assigned to the pregnancy).
In a secondary analysis, we expanded our preterm definition to
FIGURE 2 Potential impact of delayed recording of hospital pregnancies in Clinical Practice Research Datalink (CPRD) on agreement between
data sources [Colour figure can be viewed at wileyonlinelibrary.com]
FIGURE 3 Retrospective recording of
historical pregnancies in Clinical Practice
Research Datalink (CPRD) [Colour figure can
be viewed at wileyonlinelibrary.com]
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include additional deliveries with estimated gestational age of less
than 259 days (less than 37 weeks).
3 | RESULTS
3.1 | Pregnancy Register profile
The February 2018 version of the Pregnancy Register included
5 824 381 pregnancies among 2 438 493 women overall, of which
1 503 685 (pregnancies) occurred during up‐to‐standard follow‐up,
among 765 867 women who had been registered at a practice for at
least 1 year. This latter subset comprised 291 826 early pregnancy
losses and 833 197 deliveries, of which 543 866 (65.27%) had a
Mother‐Baby link, and 24 038 (2.89%) were characterised as preterm,
57 557 (6.91%) postterm, and 6790 (0.81%) multiple births. Addition-
ally, 378 662 pregnancies with no recorded outcome were identified,
of which 33.20% were potentially ongoing when follow‐up was
censored (the earliest antenatal record in the episode was less than
38 weeks before the patient left the practice or the practice last
collection date). The distributions of pregnancies among women and
by outcome are shown in Tables 3 and 4, respectively.
Women had a median of one pregnancy (interquartile range [IQR]
1‐2 pregnancies) and less than 1% had more than seven pregnancies.
The median gestational age at delivery was 280 days (IQR 273‐280),
and median 84 days (IQR 84‐84) for early pregnancy losses. For
pregnancies with known outcomes, the median gestation at the first
antenatal record was 53 days (IQR 40‐72). Pregnancy start dates were
imputed for 42% of pregnancies with known outcomes, though for rel-
atively fewer deliveries (30%) than for early pregnancy losses (76%).
Pregnancies whose start dates were not imputed had shorter gesta-
tions (median 278 days (IQR 266‐285) for deliveries, 76 days (IQR
56‐98) for early pregnancy losses). Overall, 14.0% of women had preg-
nancy episodes that appeared to overlap (238,242 pregnancies).
3.2 | Validation results
3.2.1 | Internal validation
Deliveries
Using the linked data, we identified 386 955 women with a delivery
recorded in either the Pregnancy Register (504 331 deliveries) or in
HES (487 916 deliveries) during the study period. Overall, 442 296
matches were identified (deliveries captured in both data sources less
than 12 weeks apart) among 328 450 women (84.9% of the delivery
cohort) (Figure 4). A large majority of Register deliveries had a corre-
sponding HES delivery (potential PPV 87.7%). The remaining 12.3%
TABLE 3 Pregnancy distribution in women aged 11 to 49 years in
the Clinical Practice Research Datalink (CPRD) GOLD Pregnancy
Register from January 1, 1987, to February 28, 2018
Number of Pregnanciesa (n) Women with n Pregnancies, N (%)
1 383 196 (50.03)
2 198 859 (25.97)
3 94 859 (12.39)
4 46 561 (6.08)
5 22 002 (2.87)
6 10 568 (1.38)
7 4982 (0.65)
8 2465 (0.32)
9 1195 (0.16)
10+ 1180 (0.15)
Total women 765 867 (100)
aRefers to pregnancies of women registered for at least 1 year at a practice
contributing research quality data.
TABLE 4 Distribution of pregnancy outcomes in the CPRD GOLD
Pregnancy Register from January 1, 1987, to February 28, 2018
Pregnancy Outcome Frequency (%)
Live birth 786 647 (52.31)
Stillbirth 3515 (0.23)
Live birth and stillbirth 32 (0.00)
Miscarriage 132 998 (8.84)
Termination (TOP) 18 052 (1.20)
Probable TOP 114 268 (7.60)
Ectopic pregnancy 11 056 (0.74)
Molar pregnancy 935 (0.06)
Blighted ovum 533 (0.04)
Unspecified loss 13 984 (0.93)
Delivery based on a third trimester code 19 915 (1.32)
Delivery based on a late pregnancy code 23 088 (1.54)
Outcome unknown 378 662 (25.18)
Total pregnanciesa 1 503 685 (100)
Abbreviations: CPRD, Clinical Practice Research Datalink; TOP, termina-
tion of pregnancy.
aRefers to pregnancies of women registered for at least 1 year at a practice
contributing research quality data.
FIGURE 4 Venn diagram of deliveries (live births and stillbirths)
identified in Clinical Practice Research Datalink (CPRD) GOLD and
Hospital Episode Statistics (HES) [Colour figure can be viewed at
wileyonlinelibrary.com]
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(n = 62 035) had no HES match. Similarly, most HES deliveries had a
corresponding Register delivery (sensitivity 90.7%). The remaining
9.3% (n = 45 620) had no Register match.
A total of 50.9% of matched deliveries had the same date of deliv-
ery in each data source, and 94.9% differed by no more than 2 days.
The median days' difference between matched delivery dates (Regis-
ter date minus HES date) was 0 days (IQR −2 to 0 days). A record of
gestational age in the HES maternity file was present for 304 982
(69.0%) matched deliveries. The median weeks' difference in gesta-
tional age for matched delivery pairs (Register minus HES) was 0 weeks
(IQR 0‐0 weeks); the mean difference was 0.13 weeks.
Early pregnancy losses
We identified 160 839 women with an early pregnancy loss recorded
in the Pregnancy Register (185 573 losses) or in HES (89 464) during
the study period. Overall, 69 613 matches were identified among
60 115 women (37.4% of the pregnancy loss cohort) (Figure 5);
37.5% of Register losses had an HES match. A higher proportion of
HES losses had a Register match (sensitivity 76.9%); 115 960 Register
losses and 20 694 HES losses had no match.
A total of 47.4% of matched pregnancy losses had the same date in
each data source, and 85.1% differed by no more than 2 days.
The median days' difference between matched pregnancy loss dates
(Register date minus HES date) was 0 days, IQR: −1 to 0 days.
Sensitivity analyses
Excluding 60 429 Register deliveries and 27 587 Register losses within
the first 6 months of follow‐up led to modest increases in potential
PPV (88.9% for deliveries, 38.2% for losses). Similarly, excluding
100 804 Register deliveries and 34 067 Register losses in the first year
of registration marginally increased potential PPV (88.3% and 38.4%,
respectively). Excluding 52 164 HES deliveries and 7 887 HES losses
within the last 6 months of follow‐up increased sensitivity to 93.2%
for deliveries and 78.6% for losses.
3.3 | External validation
Our external validation findings comparing pregnancy outcome rates
in the Pregnancy Register with external estimates from Office for
National Statistics (ONS) and other published evidence are shown in
Table 5. Our algorithm identified 21 806 live births and 317 termina-
tions (3489 including “probable terminations” and “unspecified losses”)
among 599 493 women (472 283 women‐years) in 2015, generating
lower rates of live birth (46.17) and terminations (0.67‐7.39) per
1000 women‐years compared with external estimates (62.32 live
births21 and 16.59 terminations22 per 1000 women); 271 090 preg-
nancies with known outcomes occurred in the Register between
2010 and 2015, of which 33 722 ended in miscarriage (35 763 includ-
ing “unspecified losses”), producing miscarriage rates of 12.44% to
13.19% consistent with external estimates (12.5% to 20%).23,24 Of
the 21 892 Register deliveries in 2015, 782 were flagged as preterm
by the algorithm, and a further 1059 were identified as preterm based
on gestational age, increasing the prematurity rate to 8.41%, consis-
tent with ONS (7.91%).25
4 | DISCUSSION
Our goal was to establish a useful research tool for researchers plan-
ning to use CPRD data for pregnancy studies. The resulting Pregnancy
Register, comprising more than 5.8 million pregnancies (more than 1.5
million meeting patient and practice‐level data quality standards)
among 2.4 million women, spanning three decades, is the first of its
kind in a UK primary care database. Our assessment of the internal
and external validity of our algorithm to determine pregnancy epi-
sodes demonstrates high validity in identifying and dating hospital
deliveries (91% sensitivity, 95% with date agreement within 2 days),
and 77% sensitivity for hospital‐based early pregnancy losses (85%
with date agreement within 2 days). Miscarriage rates in the Preg-
nancy Register of 12% to 13% compared favourably with estimates
from external sources, whereas lower rates were observed for termi-
nations and live births. Prematurity rates were lower when based
solely on preterm evidence in pregnancy codes but improved
markedly when gestational age was taken into account (8%). Overall,
the scale and scope of pregnancies captured in the Register and our
validation findings demonstrate the potential of this data resource to
enhance future CPRD‐based pregnancy research.
Our algorithm has several advantages over previous pregnancy‐
identification approaches in CPRD. A key strength is our use of all
available pregnancy data across the entire patient record, including
additional clinical details (entity codes) recorded in structured data
FIGURE 5 Venn diagram of early pregnancy
losses identified in Clinical Practice Research
Datalink (CPRD) GOLD and Hospital Episode
Statistics (HES) [Colour figure can be viewed
at wileyonlinelibrary.com]
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areas to characterise and estimate the timing of each pregnancy. In
contrast to previous approaches, we impose no restrictions regarding
the completeness13 or timing7 of recording. Hence, pregnancy epi-
sodes based on a single antenatal code and historical pregnancies
occurring prior to patient registration are included in the Register. This
allows us to capture all documented pregnancy episodes, including
pregnancies with no recorded outcome, which recent approaches
have not addressed.7,13 While such pregnancy episodes can be chal-
lenging to interpret, ignoring them is potentially more problematic
and could lead to bias, particularly for studies requiring a denominator
of pregnant women such as vaccine uptake studies. When outcomes
are recorded, we use all available records to classify the episode,
including differentiating between induced and spontaneous abortions
whenever possible, rather than combining these episodes in a single
“abortion” category as a recent approach has done.13
A key feature of our algorithm is it avoids preferentially selecting
one type of pregnancy outcome over another. Because delivery epi-
sodes are generated separately from early pregnancy loss episodes,
we are able to distinguish distinct pregnancy episodes for each type
of outcome from multiple records corresponding to the same
pregnancy, without choosing between outcomes when a patient has
successive records of both (eg, a delivery code followed by a miscar-
riage code). By contrast, previous approaches discard pregnancy
outcome records occurring within a pre‐specified time period after a
patient's previous outcome, disregarding the type of outcome
specified in the records, which could potentially result in incomplete
ascertainment of distinct pregnancy episodes of different types.13
For studies of live birth pregnancies, a clear advantage of our
approach is linkage between the Register and the Mother‐Baby link,
which enables outcomes recorded in infant records, such as congenital
malformations, to be assessed. However, 31% of Register deliveries
(excluding stillbirths and deliveries based on late pregnancy or third
trimester codes) had no linked infant. Because the Mother‐Baby link-
age is based on GP practice and requires that the estimated delivery
date and infant birth date (derived from month of birth) are less than
or equal to 60 days apart, incomplete linkage may occur if the infant
is not registered at the mother's practice during the data collection
period, or due to imprecision in delivery or birth date estimates
resulting in more than 60 days difference. The inclusion of some his-
torical deliveries or possible misclassification of some stillbirths as live
births in the Register may also partly explain the incomplete linkage.
A further strength of our approach is its transparency. We provide
full details of our algorithm stages in the Supporting information,
including our complete categorised pregnancy code lists (read and
entity codes). This enables researchers planning to use the Pregnancy
Register to understand its scope and assess its applicability for their
particular study questions. The provision of a data field “start source”
in the Register enables researchers to determine how pregnancy start
dates were derived, eg, through imputation or from the available data.
When assessing capture of HES deliveries in the Register, high con-
cordancewas found. Some of the 9% of HES deliveries with no Register
match could be deliveries with feedback from secondary care that were
not coded by the practice but simply documented in free text fields of
the practice software (which are unavailable to researchers). The
incomplete concordance we observed between deliveries in the Regis-
ter and those in HES may partly be due to approximately 4% of deliver-
ies occurring at home, in private hospitals or in hospitals outside
England.26 Indeed, we would not expect 100% PPV for Register deliv-
eries for this reason. Nevertheless, this is unlikely to explain the remain-
ing 8% of Register deliveries with no HES match.
A surprising finding from our external validation is the lower live birth
rate in the Register compared with ONS in 2015, despite the high sensi-
tivity we observed in comparison with HES. It is possible that HES‐linked
practices have different completeness of recording of live births than
practices not linked to HES. Because our Register‐ONS comparison
includes practices that are not HES‐linked, the lower Register live birth
TABLE 5 Comparison of pregnancy outcome rates in the CPRD
GOLD Pregnancy Register with external estimates
Pregnancy Outcome,
Calendar Period
CPRD GOLD
Pregnancy Register
Rate (95% CI)
External
Comparison Rate
(Data Source)
Live birth ratea, 2015
Primary analysis 46.17 (45.56‐46.79) 62.32 (ONS)
Sensitivity analysis (includes
first year of registration)
51.55 (50.94‐52.16)
Miscarriage rateb, 2010‐2015
Primary analysis (miscarriage) 12.44 (12.32‐12.56) 12.5 (NHS), 11‐20
(Ammon Avalos
et al, 2012)
Secondary analysis
(miscarriage and
unspecified loss)
13.19 (13.07‐13.32)
Termination ratea, 2015
Primary analysis (TOP) 0.67 (0.60‐0.75) 16.59 (DHSC)
Secondary analysis 1 (TOP
and probable TOP)
6.98 (6.74‐7.22)
Secondary analysis 2 (TOP,
probable TOP and
unspecified loss)
7.39 (7.14‐7.64)
Sensitivity analysis (includes
first year of registration)
0.72 (0.65‐0.80)
Prematurity rateb, 2015
Primary analysis (preterm
flagc)
3.57 (3.33‐3.83) 7.91 (ONS)
Secondary analysis (preterm
flagc and estimated
gestational age < 259 d)
8.41 (8.05‐8.78)
Abbreviations: CI, confidence interval; DHSC, Department of Health and
Social Care; NHS, National Health Service; ONS, Office for National Statis-
tics; TOP, termination of pregnancy.
aLive birth and termination rates are per 1000 women‐years (Pregnancy
Register), per 1000 women (external).
bMiscarriage rates are per 100 pregnancies, prematurity rates are per 100
deliveries (live birth and stillbirth).
cBased on evidence in read and entity codes assigned to the pregnancy.
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rate could be due to these practices missing some live births. Any such
difference in completeness of recording of live births in HES‐linked prac-
tices versus practices not linked to HES may limit the generalisability of
our internal validation findings to the whole Pregnancy Register.
Other potential reasons for incomplete matching of pregnancy out-
comes in the Register and HES include possible reporting delays, or ret-
rospective recording of past pregnancies in primary care. Our
sensitivity analysis findings provide some support for this: excluding Reg-
ister and HES pregnancies in the first and last 6 months of follow‐up and
Register pregnancies recorded in the first year of registrationwith a prac-
tice, marginally improved the algorithm performance, both in terms of
PPV and completeness for deliveries and early pregnancy losses. Incom-
plete capture or misclassification of pregnancy outcomes in either data
source could also partly explain the lack of concordance. Themedian ges-
tation at the first antenatal record among Register pregnancies was
7.6 weeks, which suggests that a proportion of pregnancies resulting in
early miscarriage would not be identified in the Register.
The higher agreementwe observedwithHES for deliveries compared
with early pregnancy losses could partly be due towomenwho give birth
having increased opportunity for their pregnancy outcomes to be
recorded throughGP consultationswith their babies, thanwomenwhose
pregnancies do not yield an infant. Furthermore, because of difficulties
distinguishing between types of early pregnancy loss in HES, our analysis
includes a heterogeneous group of outcomes (miscarriages, terminations,
ectopic pregnancies etc.) However, we would expect miscarriages to be
better recorded than terminations due to a substantial proportion of ter-
minations being carried out in specialist clinics outside of NHS hospitals.
Our validation findings of similar miscarriage rates yet lower termination
rates in the Register compared with external sources reflect this.
There are limitations to our algorithm that are important to consider
when using the Register. While our algorithm maximises all available
pregnancy data, the reverse side of this approach is that some identified
pregnancies included in the Register may represent historical events
discussed during a consultation and recorded with the current date.
However, researchers can apply restrictions on data occurring within
patient registration and practice‐level up‐to‐standard follow‐up if
required for their particular study question. Our validation analyses
restricted to pregnancies occurring during up‐to‐standard follow‐up,
hence the findings are not necessarily generalisable to pregnancies
occurring before the practices' data were deemed up‐to‐standard.
Uncovering pregnancy episodes with no discernible outcome is
also a consequence of our approach to maximise completeness of
pregnancy ascertainment. Overall, these “outcome unknown” preg-
nancy episodes comprise 25% of all research‐quality pregnancies in
the Register (among women registered for at least 1 year, at an up‐
to‐standard practice). This is consistent with more than 20% of these
types of pregnancies identified in an earlier pregnancy record mapping
algorithm using CPRD.8 Our findings suggest that one‐third of these
pregnancy episodes with unknown outcome are potentially ongoing
pregnancies; however, the remainder are more difficult to interpret.
Such episodes may occur for a number of reasons, for example, some
may represent undocumented miscarriages requiring no medical inter-
vention or early pregnancy losses with feedback from secondary care
that were not captured in the coded data. Variability in the PPV of cer-
tain codes used to identify pregnancies, for example, codes which
relate to pregnancy planning rather than a current pregnancy, might
also explain some of these outcome unknown episodes. Comparing
the estimated pregnancy dates in the Register with the date follow‐
up is censored can help researchers decide whether a pregnancy is
potentially or unlikely to be ongoing.
A further caveat of our approach is that it yields some patients'
pregnancy episodes that appear to overlap. While some overlapping
episodes may be an artefact of GP recording practices (for example,
an apparent pregnancy loss nested within a delivery episode may
represent a threatened miscarriage recorded as a “miscarriage,”
culminating in a later delivery), others may arise from errors in date esti-
mation. While these episodes also present interpretational challenges,
we do not attempt to resolve them. Instead, such episodes are flagged
as “conflicts” in the Register, allowing researchers to judge how best to
handle them in the context of their own study questions. Characterising
these “outcome unknown” and overlapping pregnancy episodes and
exploring potential reasons for their occurrence are key areas of ongo-
ing validation work to improve the Pregnancy Register.
5 | CONCLUSIONS
We have described our approach to identifying and characterising
pregnancies in the CPRD GOLD database and establishing a new data
resource for pregnancy studies using CPRD data. The Pregnancy Reg-
ister is available to researchers alongside existing CPRD GOLD
datasets, upon receipt of ISAC approval of a study protocol. Further
work to refine the Register and to extend it to data contributed by
practices using EMIS software (CPRD Aurum) is ongoing.
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